OA09.04 Osimertinib with or without SRS for Brain Metastases from EGFRm NSCLC: Pooled Analysis of Two RCTs

• DOI: 10.1016/j.jtho.2024.09.054
• Publication Date: 2024-10-16T02:32:42Z
• Authors: C. Ho; Y.Y. Soon; A. Nichol; K. Robledo; A. Sahgal; M. Pinkham; B. Melosky; Y. Huang; A. Parmar; B. Solomon; I.W.K. Tham; A. Sacher; J.C.S. Tey; I. Menjak; C.N. Leong; D. Shultz; W.Y. Koh; M. Doherty; Y. Ang; J. Low; C. Yong; M.C. Lim; A.P. Tan; C.K. Lee; R. Soo; S. Lefresne; F. Hegi-Johnson